CN1090936C - Compound preparation for curing acne - Google Patents

Compound preparation for curing acne Download PDF

Info

Publication number
CN1090936C
CN1090936C CN99112948A CN99112948A CN1090936C CN 1090936 C CN1090936 C CN 1090936C CN 99112948 A CN99112948 A CN 99112948A CN 99112948 A CN99112948 A CN 99112948A CN 1090936 C CN1090936 C CN 1090936C
Authority
CN
China
Prior art keywords
powder
compound preparation
acne
dermatitis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99112948A
Other languages
Chinese (zh)
Other versions
CN1240135A (en
Inventor
张广政
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99112948A priority Critical patent/CN1090936C/en
Publication of CN1240135A publication Critical patent/CN1240135A/en
Application granted granted Critical
Publication of CN1090936C publication Critical patent/CN1090936C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention discloses a compound preparation for curing acne, which is composed of metronidazole powder, sulfamethoxazole powder, chloramphenicol powder, salicylic acid powder and benadryl powder, and the powders are blended with high-grade aliphatic alcohol into paste. The compound preparation can be used for treating acnes of different types, and can also be used for treating the diseases of allergic dermatitis, eczema, seborrheic dermatitis, atopic dermatitis, hand and foot tinea cruris, folliculitis, flat wart, etc. The present invention is mainly used for external application, and has the advantages of mild medicinal property, smooth, nourishing and moistening feeling after coating and no toxic or side effect basically.

Description

A kind of compound formulation for the treatment of acne
The invention belongs to a kind of medicine for the treatment of acne, exactly is a kind of compound formulation for the treatment of acne.
Acne is commonly encountered diseases, the frequently-occurring disease among the young crowd, affect patient's beautifying face health, though there are many medicines that acne is had certain curative effect, as acne ointment, acne spirit etc., its effect is to reduce local fat secretion, eliminates the hair follicle inflammation, cures the symptoms, not the disease, the patient needs life-time service, could keep therapeutic effect.And diseases such as seborrheic dermatitis, folliculitis, eczema, verruca plana are of no curative effect.
The objective of the invention is to disclose a kind of compound formulation for the treatment of acne, treating both the principal and secondary aspects of a disease, and can treat diseases such as seborrheic dermatitis, folliculitis, eczema, verruca plana.
The present invention is made up of metronidazole powder, sulfamethoxazole powder, chlormycetin powder, salicylic acid powder, diphenhydramine powder, presses following weight portion proportioning:
Metronidazole powder 20~35 sulfamethoxazole powder 6~10 chlormycetin powders 10~20
Salicylic acid powder 1~3 diphenhydramine powder 8~15
Above-mentioned medicated powder is puddled evenly, and the high fatty alcohol that adds 2~5 times is made unguentum.
The present invention has more the effect that anti-inflammation, reducing swelling and alleviating pain are antipruritic, promote skin repair than other similar medicine, can also play certain cosmetic result.Through 180 routine clinical trials, 156 examples of fully recovering account for 88.6%, and 24 examples that take a turn for the better account for 11.4%, and total effective rate is 100%.The present invention also can be used for treating diseases such as allergic dermatitis, eczema, seborrheic dermatitis, atoipc dermatitis, brothers' tinea cruris, folliculitis, verruca plana when treating dissimilar acnes.
With preceding cleaning affected part, be coated with every day and put 2~3 times on the skin at every turn, effect is obvious after 2~3 days, and after one month, acne disappears, skin Lightening, no cicatrix, no stain.Property of medicine gentleness is mainly used in outer being coated with, and smooth moisture feeling is now arranged after being coated with, and has no side effect substantially.
Further specify the present invention below in conjunction with embodiment:
Embodiment 1
With metronidazole powder 35g, sulfamethoxazole powder 10g, chlormycetin powder 20g, salicylic acid powder 3g, diphenhydramine powder 15g, mixing and stirring is got mixture 10g and is added vanishing cream 40g, mixes well and makes paste.
Embodiment 2
Get metronidazole powder 30g, sulfamethoxazole powder 8g, chlormycetin powder 15g, salicylic acid powder 2g, diphenhydramine powder 15g, mixing and stirring is got mixture 10g and is added emollient cream 30g, mixes well and makes paste.
Embodiment 3
With metronidazole powder 20g, sulfamethoxazole powder 6g, chlormycetin powder 10g, salicylic acid powder 1g, diphenhydramine powder 8g, mixing and stirring is got mixture 10g and is added vanishing cream 50g, mixes well and makes paste.

Claims (1)

1, a kind of compound formulation for the treatment of acne is characterized in that it being to be formed by weight ratio by following medicine:
Metronidazole powder 20~35 sulfamethoxazole powder 6~10 chlormycetin powders 10~20
Salicylic acid powder 1~3 diphenhydramine powder 8~15
Above-mentioned medicated powder is puddled evenly, and the high fatty alcohol that adds 2~5 times is made unguentum.
CN99112948A 1999-05-19 1999-05-19 Compound preparation for curing acne Expired - Fee Related CN1090936C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99112948A CN1090936C (en) 1999-05-19 1999-05-19 Compound preparation for curing acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99112948A CN1090936C (en) 1999-05-19 1999-05-19 Compound preparation for curing acne

Publications (2)

Publication Number Publication Date
CN1240135A CN1240135A (en) 2000-01-05
CN1090936C true CN1090936C (en) 2002-09-18

Family

ID=5276190

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99112948A Expired - Fee Related CN1090936C (en) 1999-05-19 1999-05-19 Compound preparation for curing acne

Country Status (1)

Country Link
CN (1) CN1090936C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005400A1 (en) * 1999-07-16 2001-01-25 Shoei Co., Ltd. Nitroimidazole external preparations for dermatosis
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
CN101229180B (en) * 2007-01-23 2011-04-20 吴金霞 Assembled medicine for treating bedsore

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1183962A (en) * 1997-08-28 1998-06-10 曾爱萍 Liquid medicine for acne
CN1208614A (en) * 1998-08-18 1999-02-24 蒋泽栋 Cream for treating acne

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1183962A (en) * 1997-08-28 1998-06-10 曾爱萍 Liquid medicine for acne
CN1208614A (en) * 1998-08-18 1999-02-24 蒋泽栋 Cream for treating acne

Also Published As

Publication number Publication date
CN1240135A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
US6911211B2 (en) Pharmaceutical and cosmetic carrier or composition for topical application
EP1614430B1 (en) Compositions containing anti-acne agents and the use thereof
US5854291A (en) Pain reliever and method of use
US20130184242A1 (en) Pharmaceutical Composition for Topical Application
US20060083708A1 (en) Composition using mineral salts for cosmetic or therapeutic treatment
WO2010097643A1 (en) Formulation based on micronized zeolite, green tea extract, and genistein as a therapeutic agent for reduction of body weight and cellulite
CN103585044A (en) Cleaning care solution and manufacturing process thereof
CN1090936C (en) Compound preparation for curing acne
US20200030398A1 (en) Skin care composition
US10588979B1 (en) Cannabinoid and terpene-infused topical cream
US20050152993A1 (en) Composition for and method of treatment for skin ailments
CN1953732A (en) Topical cypress essential oil composition for stretch marks
CN1706381A (en) Frostbite and chilblain treating ointment
CN1224406C (en) Medical ointment Jiaoxuanxiao for treating beriberi
CN110812377B (en) Acne treatment and repair composition and application thereof
CN1240408C (en) Ointment for treating chilblain
CN109045029A (en) A kind of purposes of imidazopyridine derivatives
CN1058866C (en) Medicinal composition for treating tinea manus and pedis
CN1104909A (en) Medicine for scald
KR20090011673A (en) Skin external composition for treating pimple
EP1249242B1 (en) Natural-Phytotherapic composition based on hydroglyceric extracts for aerosol therapy
CN112245339A (en) Traditional Chinese medicine mask
CN100411627C (en) Desensitization face pack for treating facial dermatitis
CN101455760A (en) Combination method of inflammation-diminishing and pain-reducing paste
CN1927210A (en) Sterilization film coating agent for burn and scald wound

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20020918

Termination date: 20110519